SCHEMBL4669937

SCHEMBL4669937

Nc1c([N+](=O)[O-])ccnc1NCCNc1cnc([N+](=O)[O-])c(-c2ccc(Cl)cc2Cl)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 6/20 0.50
GSK3A P49840 3/20 0.50
CDK1 P06493 2/20 0.50
CCNB2 O95067 1/20 0.49
CCNB1 P14635 1/20 0.49
CCNB3 Q8WWL7 1/20 0.49
STK17A Q9UEE5 1/20 0.39
MAPT P10636 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
CASP3 P42574 1/20 0.38
RAB9A P51151 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14175422 0.85 GSK3B (0.64) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL4675036 0.84 GSK3B (0.51) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL4675353 0.83 GSK3B (0.50) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL5076249 0.80 GSK3B (0.62) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL4672350 0.80 GSK3B (0.51) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL6402266 0.78 GSK3B (0.43) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL4669974 0.78 GSK3B (0.47) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL5076233 0.77 GSK3B (0.43) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL4669938 0.77 GSK3B (0.66) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL5082188 0.77 GSK3B (0.54) GSK3BGSK3ACDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1237880-B1 PYRAZINE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2008-01-23 EP disclosed